GB Sciences EBITDA vs. Market Capitalization

GBLX Stock  USD 0.01  0  35.00%   
Based on GB Sciences' profitability indicators, GB Sciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in May. Profitability indicators assess GB Sciences' ability to earn profits and add value for shareholders.
For GB Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GB Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GB Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GB Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GB Sciences over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between GB Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if GB Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GB Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

GB Sciences Market Capitalization vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining GB Sciences's current stock value. Our valuation model uses many indicators to compare GB Sciences value to that of its competitors to determine the firm's financial worth.
GB Sciences is one of the top stocks in ebitda category among related companies. It is one of the top stocks in market capitalization category among related companies creating about  20.59  of Market Capitalization per EBITDA. Comparative valuation analysis is a catch-all model that can be used if you cannot value GB Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GB Sciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GB Sciences' earnings, one of the primary drivers of an investment's value.

GBLX Market Capitalization vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

GB Sciences

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
398.73 K
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

GB Sciences

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
8.21 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

GBLX Market Capitalization vs Competition

GB Sciences is one of the top stocks in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 23.38 Billion. GB Sciences adds roughly 8.21 Million in market capitalization claiming only tiny portion of stocks in Biotechnology industry.
Capitalization  Valuation  Revenue  Total debt  Workforce

GB Sciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in GB Sciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GB Sciences will eventually generate negative long term returns. The profitability progress is the general direction of GB Sciences' change in net profit over the period of time. It can combine multiple indicators of GB Sciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

GBLX Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on GB Sciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GB Sciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GB Sciences' important profitability drivers and their relationship over time.

Use GB Sciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GB Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GB Sciences will appreciate offsetting losses from the drop in the long position's value.

GB Sciences Pair Trading

GB Sciences Pair Trading Analysis

The ability to find closely correlated positions to GB Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GB Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GB Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GB Sciences to buy it.
The correlation of GB Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GB Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GB Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GB Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your GB Sciences position

In addition to having GB Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Preferred Stock ETFs Thematic Idea Now

Preferred Stock ETFs
Preferred Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for GBLX Pink Sheet analysis

When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
To fully project GB Sciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of GB Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include GB Sciences' income statement, its balance sheet, and the statement of cash flows.
Potential GB Sciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although GB Sciences investors may work on each financial statement separately, they are all related. The changes in GB Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GB Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.